Literature DB >> 2854339

Protective immunity against avian influenza induced by a fowlpox virus recombinant.

J Taylor1, R Weinberg, Y Kawaoka, R G Webster, E Paoletti.   

Abstract

Fowlpox virus, the prototypic virus of the genus Avipoxvirus has a natural host range limited to avian species. As such, fowlpox virus provides a suitable candidate for the development of a species-specific recombinant viral vector. This paper reports the development of a fowlpox virus recombinant expressing the haemagglutinin molecule from a highly virulent avian influenza virus. On immunization of chickens and turkeys with the recombinant, protection is afforded against a lethal challenge with either the homologous or a heterologous influenza virus strain.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2854339     DOI： 10.1016/0264-410x(88)90101-6

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  34 in total

1.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats.

Authors:  Kemal Karaca; David E Swayne; Deborah Grosenbaugh; Michel Bublot; Amy Robles; Erica Spackman; Robert Nordgren
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

3.  Anoikis-resistant MDCK cells carrying susceptibilities to TNF-alpha and verotoxin that are suitable for influenza virus cultivation.

Authors:  Reiko Tsutsumi; Shigemi Fujisaki; Masanori Shozushima; Koichi Saito; Shigehiro Sato
Journal:  Cytotechnology       Date:  2006-11-30       Impact factor: 2.058

4.  Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.

Authors:  M E Perkus; K Limbach; E Paoletti
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

Review 5.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection.

Authors:  Donata Kalthoff; Anatoli Giritch; Katharina Geisler; Ulrike Bettmann; Victor Klimyuk; Hans-Robert Hehnen; Yuri Gleba; Martin Beer
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

7.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  The live vector approach-viruses.

Authors:  M Mackett
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

9.  Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants.

Authors:  D B Boyle
Journal:  Virus Genes       Date:  1992-08       Impact factor: 2.332

10.  Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.

Authors:  Baibaswata Nayak; Subrat N Rout; Sachin Kumar; Mohammed S Khalil; Moustafa M Fouda; Luay E Ahmed; Kenneth C Earhart; Daniel R Perez; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.